These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 7685527

  • 1. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K, Ishiguro T.
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [Abstract] [Full Text] [Related]

  • 2. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS.
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [Abstract] [Full Text] [Related]

  • 3. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K, Ishiguro T.
    Seishin Shinkeigaku Zasshi; 1989 Jul; 91(6):429-56. PubMed ID: 2479043
    [Abstract] [Full Text] [Related]

  • 4. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT.
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [Abstract] [Full Text] [Related]

  • 5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 6. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Nov; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 7. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Res Publ Assoc Res Nerv Ment Dis; 1976 Nov; 55():459-65. PubMed ID: 1070064
    [Abstract] [Full Text] [Related]

  • 8. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 9. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR.
    Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 01; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E, Alling C, Andersch B, Andersson K, Berggren U.
    Neuropsychopharmacology; 1994 Nov 01; 11(3):201-13. PubMed ID: 7532413
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR.
    Ann Neurol; 1987 Apr 01; 21(4):408-11. PubMed ID: 2437853
    [Abstract] [Full Text] [Related]

  • 13. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
    Petrakis IL, Trevisan L, D'Souza C, Gil R, Krasnicki S, Webb E, Heninger G, Cooney N, Krystal JH.
    Alcohol Clin Exp Res; 1999 Aug 01; 23(8):1336-41. PubMed ID: 10470976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May 01; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 16. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA.
    J Neurosurg Pediatr; 2014 Apr 01; 13(4):375-9. PubMed ID: 24559277
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Apr 01; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid monoamine metabolite levels in human newborn infants born in winter differ from those born in summer.
    Chotai J, Murphy DL, Constantino JN.
    Psychiatry Res; 2006 Dec 07; 145(2-3):189-97. PubMed ID: 17074397
    [Abstract] [Full Text] [Related]

  • 19. Gilles de la Tourette's syndrome in twins: clinical and neurochemical data.
    Goetz CG, Tanner CM.
    Mov Disord; 1990 Dec 07; 5(2):173-5. PubMed ID: 1691443
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA.
    Bipolar Disord; 2006 Oct 07; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.